Nurse Practitioner - Therapy for Multi-Drug Resistant Strep in CAP
Sunday, January 11th, 2009Levofloxacin (Levaquin) is now approved by the FDA to treat multidrug-resistant strains of Streptococcus pneumoniae in community-acquired pneumonia (CAP), in the forms of tablets, injection, and in 5% dextrose (Levaquin Injection). Levofloxacin is a product of Johnson & Johnson….
